Scalper1 News
Alexion Pharmaceuticals (ALXN) stock rocketed Thursday, after the maker of drugs for blood, neurological and other diseases late Wednesday issued Q4 earnings and sales that beat forecasts. The Cheshire, Conn.-based firm also gave a better-than-expected forecast for 2014, based on improving sales and reduced tax payments that spurred investors. Alexion stock was up 22%, near 163, in afternoon trading in the stock market today. Alexion stock ranks Scalper1 News
Scalper1 News